The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Open accessAbstract
Background Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades. To assess whether this pathway is causally relevant to coronary heart disease, we studied a functional genetic variant known to affect IL6R signalling.Methods In a collaborative meta-analysis, we studied Asp358Ala (rs2228145) in IL6R in relation to a panel of conventional risk factors and inflammation biomarkers in 125,222 participants. We also compared the frequency of Asp358Ala in 51,441 patients with coronary heart disease and in 136,226 controls. To gain insight into possible mechanisms, we assessed Asp358Ala in relation to localised gene expression and to postlipopolysaccharide stimulation of interleukin 6.Findings The minor allele frequency of Asp358Ala was 39%. Asp358Ala was not associated with lipid concentrations, blood pressure, adiposity, dysglycaemia, or smoking (p value for association per minor allele ≥0·04 for each). By contrast, for every copy of 358Ala inherited, mean concentration of IL6R increased by 34·3% (95% CI 30·4-38·2) and of interleukin 6 by 14·6% (10·7-18·4), and mean concentration of C-reactive protein was reduced by 7·5% (5·9-9·1) and of fibrinogen by 1·0% (0·7-1·3). For every copy of 358Ala inherited, risk of coronary heart disease was reduced by 3·4% (1·8-5·0). Asp358Ala was not related to IL6R mRNA levels or interleukin-6 production in monocytes.Interpretation Large-scale human genetic and biomarker data are consistent with a causal association between IL6R-related pathways and coronary heart disease.Funding British Heart Foundation; UK Medical Research Council; UK National Institute of Health Research, Cambridge Biomedical Research Centre; BUPA Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“genetic evidence suggests that IL-6 may be causal for atherosclerotic cardiovascular disease, 24,25”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Scott, D. L., Wolfe, F., & Huizinga, T. W. J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,263
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,389
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
Cardiogenics, Schunkert, H., the CARDIoGRAM Consortium, König, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., Preuss, M., Stewart, A. F. R., et al. (2011) · Nature Genetics · doi:10.1038/ng.784 · Cited by 1,866
Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality
Danesh, J., Lewington, S., Thompson, S. G., Lowe, G. D. O., Collins, R., Kostis, J. B., Wilson, A. C., Folsom, A. R., Wu, K., Benderly, M., et al. (2005) · JAMA · doi:10.1001/jama.294.14.1799 · Cited by 1,162
Population genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Research works printed but not linked: 2
- Lamas, 2011, Mechanisms underlying the generation of soluble IL-6 soluble receptor (sIL-6R) in rheumatoid arthritis: mRNA alternative splicing and proteolytic cleavage as independent contributors, Arthritis Rheum, 63, 383
- Genovese, 2009, Analysis of low-density lipoprotein and adverse events in rheumatoid arthritis patients treated with tocilizumab plus statins: data from five phase III clinical trials, Rheumatology (Oxford), 48, I81
Cited by
Sorted by citations
Items 401–500 of 823
Mendelian Randomization and Type 2 Diabetes
Swerdlow, D. I. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6638-5 · Cited by 27
Flynn, C. M., Garbers, Y., Düsterhöft, S., Wichert, R., Lokau, J., Lehmann, C. H. K., Dudziak, D., Schröder, B., Becker-Pauly, C., Rose-John, S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77884-4 · Cited by 19
Unravelling the broader complexity of IL-6 involvement in health and disease
Jenkins, R. L., Hughes, S. T. O., Figueras, A. C., & Jones, S. A. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155684 · Cited by 25
Zhang, M., Bai, Y., Wang, Y., Cui, H., Tang, M., Wang, L., Wang, X., & Gu, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.860703 · Cited by 25
Yang, F., Xu, F., Zhang, H., Gill, D., Larsson, S. C., Li, X., Cui, H., & Yuan, S. (2023) · BMC Medicine · doi:10.1186/s12916-023-03197-8 · Cited by 30
Ma, Y., Yuan, X., Deng, L., Xu, W., Zheng, Y., Yue, C., Zhang, G., Xie, F., Yang, Y. H., Gantier, M. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072804 · Cited by 25
Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease
Ong, K. L., Chung, R. W. S., Hui, N., Festin, K., Lundberg, A. K., Rye, K., Jonasson, L., & Kristenson, M. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.11.016 · Cited by 27
Inflammation in Atherosclerosis
Lauterbach, M., Labzin, L. I., & Latz, E. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch49 · Cited by 26
IL ‐6 in the spotlight: From cardiovascular pathophysiology to therapy
Preda, A., Tirandi, A., Leo, G., Vece, D. D., Vilahur, G., Bonaventura, A., Osto, E., Ministrini, S., Kraler, S. C., Kleinbogard, P., et al. (2025) · European Journal of Clinical Investigation · doi:10.1111/eci.70161 · Cited by 26
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs
KONES, R. J., & Rumana, U. (2015) · Drugs · doi:10.1007/s40265-015-0429-3 · Cited by 26
Novel directions in inflammation as a therapeutic target in atherosclerosis
Verweij, S. L., van der Valk, F. M., & Stroes, E. S. G. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000233 · Cited by 24
Wang, Y., Gu, Y., Alexander, J. S., & Lewis, D. F. (2021) · Pathophysiology · doi:10.3390/pathophysiology28020013 · Cited by 25
Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
Chan, S. C. W., Teo, K. C., Li, P. H., Lau, K. K., Lau, C. S., & Chung, H. Y. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211032444 · Cited by 24
Emerging Anti-Atherosclerotic Therapies
Gluba-Brzózka, A., Franczyk, B., Rysz-Górzyńska, M., Ławiński, J., & Rysz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212109 · Cited by 28
Genetic evidence for causal effects of immune dysfunction in psychiatric disorders: where are we?
Iakunchykova, O. P., Leonardsen, E. H., & Wang, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02778-2 · Cited by 24
Bouwens, J., van Duijn, E., Cobbaert, C., Roos, R., van der Mast, R., & Giltay, E. (2016) · Journal of Huntington's Disease · doi:10.3233/jhd-160213 · Cited by 19
Systemic inflammation is associated with incident stroke and heart disease in East Asians
Karim, M. A., Kartsonaki, C., Bennett, D., Millwood, I. Y., Hill, M., Avery, D., Bian, Z., Du, H., Guo, Y., Qian, Y., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62391-3 · Cited by 24
The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health
Hirohama, D., Fadista, J., Ha, E., Liu, H., Abedini, A., Levinsohn, J. L., Vassalotti, A., Zeng, L., Li, C., Mohandes, S., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03872-8 · Cited by 28
Park, K. S., Kwak, S., Cho, Y. M., Park, K. S., Jang, H. C., Kim, S. Y., & Jung, H. S. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12572 · Cited by 23
Palmu, J., Watrous, J. D., Mercader, K., Havulinna, A. S., Lagerborg, K. A., Salosensaari, A., Inouye, M., Larson, M. G., Rong, J., Vasan, R. S., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017598 · Cited by 23
“36,37 44 Although downstream markers of inflammation are associated with hypertension and a variety of cardiovascular disease outcomes, evidence for a clinically important, causal role of these biomarkers has been mixed.”
Li, X., Peng, S., Guan, B., Chen, S., Zhou, G., Wei, Y. Q., Gong, C., Xu, J., Lu, X., Zhang, X., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.734400 · Cited by 25
Mookherjee, N., Ryu, M. H., Hemshekhar, M., Orach, J., Spicer, V., & Carlsten, C. (2022) · Environmental Research · doi:10.1016/j.envres.2022.112803 · Cited by 23
GWAS Reveal Targets in Vessel Wall Pathways to Treat Coronary Artery Disease
Turner, A. W., Wong, D., Dreisbach, C., & Miller, C. L. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00072 · Cited by 24
Jemt, T. (2019) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12812 · Cited by 23
Akl, E., Sahami, N., Labos, C., Genest, J. J., Zgheib, A., Piazza, N., & Jolly, S. S. (2024) · Journal of Interventional Cardiology · doi:10.1155/2024/8646351 · Cited by 24
Beyond the Single SNP: Emerging Developments in Mendelian Randomization in the “Omics” Era
Brion, M., Benyamin, B., Visscher, P. M., & Smith, G. D. (2014) · Current Epidemiology Reports · doi:10.1007/s40471-014-0024-2 · Cited by 22
Centurión, O. A. (2016) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2016.01.005 · Cited by 22
“The hepatocyte augments productions of acute phase reactants in the presence of systemic inflammation, notably interleukin-6 (IL-6), a pro-inflammatory cytokine strongly implicated in the pathogenesis of ACS [63].”
Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction
Mathews, S. E., Kumar, R. B., & Shukla, A. P. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000432 · Cited by 23
Blondon, M., Cushman, M., Jenny, N. S., Michos, E. D., Smith, N. L., Kestenbaum, B. R., & de Boer, I. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1368 · Cited by 22
Thanassoulis, G. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.09.014 · Cited by 21
Lorenzatti, A. J., & Retzlaff, B. M. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.061 · Cited by 23
Harada, P. H. N., Benseñor, I. M., Drager, L. F., Goulart, A. C., Mill, J. G., & Lotufo, P. A. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.02.005 · Cited by 21
Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.007 · Cited by 22
Paroxetine induced larva zebrafish cardiotoxicity through inflammation response
Zhu, Y., Song, F., Gu, J., Lin-lin, W., Wu, W., & Ji, G. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115096 · Cited by 21
Schumacher, N., Schmidt, S., Schwarz, J., Dohr, D., Lokau, J., Scheller, J., Garbers, C., Chalaris, A., Rose‐John, S., & Rabe, B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600909 · Cited by 21
Zhao, L., Wang, X., & Yang, Y. (2017) · International journal of cardiac imaging · doi:10.1007/s10554-017-1098-y · Cited by 21
López, E., Marinaro, F., de Pedro, M. Á., Sanchez-Margallo, F. M., Gómez‐Serrano, M., Ponath, V., von Strandmann, E. P., Jorge, I., Vázquez, J., Pereira, L. F., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00321 · Cited by 20
Adam, S., Liu, Y., Siahmansur, T. J., Ho, J. H., Dhage, S. S., Yadav, R., New, J. P., Donn, R. P., Ammori, B. J., Syed, A. A., et al. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119826479 · Cited by 21
Groot, H. E., Hartman, M. H. T., Gu, Y. L., de Smet, B. J. G. L., van den Heuvel, A. F. M., Lipšic, E., & van der Harst, P. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.004 · Cited by 20
Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients
Singh, J. A., & Cleveland, J. D. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1606-z · Cited by 21
Current pharmacotherapies for atherosclerotic cardiovascular diseases
Park, J., & Oh, G. T. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01116-1 · Cited by 21
Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
Samuelsson, I., Parodis, I., Gunnarsson, I., Zickert, A., Hofman‐Bang, C., Wallén, H., & Svenungsson, E. (2021) · Lupus Science & Medicine · doi:10.1136/lupus-2021-000515 · Cited by 21
Bradley, N., Walter, A., Wilson, A., Siddiqui, T., Roxburgh, C. S. D., McMillan, D. C., & Guthrie, G. J. K. (2023) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2023.04.018 · Cited by 20
Knopp, T., Jung, R., Wild, J., Bochenek, M. L., Efentakis, P., Lehmann, A., Bieler, T., Garlapati, V. S., Richter, C., Molitor, M., et al. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae046 · Cited by 21
Temas de actualidad en cardiología: riesgo vascular y rehabilitación cardiaca
Galve, E., Castro, A., Cordero, A., Dalmau, R., Fácila, L., García-Romero, A., Mazón, P., Sanmartín, M., & Garcia, A. A. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.10.009 · Cited by 20
Erqou, S. A., Kip, K. E., Mulukutla, S. R., Aiyer, A., & Reís, S. E. (2014) · Netherlands Heart Journal · doi:10.1007/s12471-014-0610-4 · Cited by 19
Targeting the Unstable Plaque in Acute Coronary Syndromes
Thompson, P. L., Nidorf, S. M., & Eikelboom, J. W. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.07.332 · Cited by 20
Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
Galve, E., Alegría, E., Cordero, A., Fácila, L., de Bobadilla, J. F., Lluís-Ganella, C., Mazón, P., Zarzosa, C. D. P., & González‐Juanatey, J. R. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.09.019 · Cited by 20
Akintoye, E. O., Briasoulis, Α., & Afonso, L. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.08.002 · Cited by 20
Zhang, H., Wang, T., Han, Z., & Liu, G. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04381-x · Cited by 21
Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries
Lavín, B., Phinikaridou, A., Andía, M. E., Potter, M., Lorrio, S., Rashid, I., & Botnar, R. M. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314387 · Cited by 20
Kim, J., Pyo, S. S., Yoon, D. W., Lee, S., Lim, J.-Y., Heo, J. S., Lee, S. K., & Shin, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206157 · Cited by 20
Cardiovascular disease and psychiatric disorders: An-up-to date review
Parlati, A. L. M., Nardi, E., Basile, C., Paolillo, S., Marzano, F., Chirico, A., Buonocore, D., Colella, A., Fontanarosa, S., Gallo, L., et al. (2024) · Journal of Public Health Research · doi:10.1177/22799036241278817 · Cited by 19
Lokau, J., Garbers, Y., Vicente, M. M., Dittrich, A., Meltendorf, S., Lingel, H., Münster-Kühnel, A. K., Brunner-Weinzierl, M. C., & Garbers, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1488745 · Cited by 20
“These individuals have reduced C-reactive protein concentrations and decreased odds of coronary heart disease events (65, 66).”
Zhang, T., Yeung, S. L. A., & Schooling, C. M. (2021) · Nutrients · doi:10.3390/nu13051489 · Cited by 19
Suh, J. S., Kim, S. H., Lee, S., Kim, R., & Park, N.-H. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12789 · Cited by 19
Wang, Y., Li, J., Johnston, S. C., Hankey, G. J., Easton, J. D., Meng, X., Shi, F., Wang, Y., Zhao, X., Li, Z., et al. (2023) · International Journal of Stroke · doi:10.1177/17474930231172312 · Cited by 19
Inflammation and Vascular Ageing: From Telomeres to Novel Emerging Mechanisms
Chiriacò, M., Georgiopoulos, G. A., Duranti, E., Antonioli, L., Puxeddu, I., Nannipieri, M., Rosada, J., Blandizzi, C., Taddei, S., Virdis, A., et al. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00331-7 · Cited by 20
Hong, E. P., Kim, D. H., Suh, J., & Park, J. W. (2014) · Hypertension Research · doi:10.1038/hr.2014.56 · Cited by 19
Cardiovascular Drug Discovery: A Perspective from a Research-Based Pharmaceutical CompanyPreprint
Gromo, G., Mann, J., & Fitzgerald, J. D. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014092 · Cited by 19
Jansen, H., Lieb, W., & Schunkert, H. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6640-y · Cited by 19
Batool, F., Patel, A. R., Gill, D., & Burgess, S. (2022) · Genetic Epidemiology · doi:10.1002/gepi.22462 · Cited by 17
“Examples include the use of variants in the HMGCR gene region to inform about the impact of statin drugs (Ference et al., 2015), and variants in the IL6R gene region about the impact of interleukin‐6 receptor inhibitors, such as tocilizumab (IL6R Genetics Consortium & Emerging Risk Factors Collaboration, 2012).”
Ryan, S. O., Johnson, J. L., & Cobb, B. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203404 · Cited by 18
Simonsen, J. R., Järvinen, A., Harjutsalo, V., Forsblom, C. M., Groop, P., & Lehto, M. J. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13138 · Cited by 17
Shen, X., Shao-hong, Z., Li, H., Xi-di, C., Jiang, L., Huang, Q., & Xu, S. (2018) · Medical Science Monitor · doi:10.12659/msm.908555 · Cited by 18
A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD
Nowak, K. L., Kakkar, R. K., Devalaraja, M., Lo, L., Park, W., Gobburu, J. V. S., Kling, D. F., Davidson, M., & Chonchol, M. (2020) · Kidney360 · doi:10.34067/kid.0005862020 · Cited by 17
Singh, H., Rai, V., & Agrawal, D. K. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1937122 · Cited by 17
Salemi, R., Gattuso, G., Tomasello, B., Lavoro, A., Gaudio, A., Libra, M., Signorelli, S. S., & Candido, S. (2022) · Biomolecules · doi:10.3390/biom12050681 · Cited by 17
Clonal hematopoiesis of indeterminate potential and cardiovascular disease
Saadatagah, S., & Ballantyne, C. M. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.013 · Cited by 17
Felipe, L. A., Bachi, A. L. L., Oliveira, M. C., Moreira, S. M. B. P., Afonso, J. P. R., Lino, M. E. M., Paixão, V., Silva, C. H. M., Vieira, R. P., Vencio, S. A. C., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00986-2 · Cited by 17
Sleep Duration Is Associated With Subclinical Carotid Plaque Burden
Agudelo, C., Ramos, A. R., Gardener, H. E., Cheung, Y. K., Elkind, M. S. V., Sacco, R. L., & Rundek, T. (2023) · Stroke · doi:10.1161/strokeaha.122.041967 · Cited by 17
Genetics of ischemic stroke functional outcome
Carnwath, T., Demel, S. L., & Prestigiacomo, C. J. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12263-x · Cited by 20
Cardiovascular disease in rheumatic diseases
Nasonov, E. L., Попкова, Т. В., & Novikova, D. S. (2016) · Terapevticheskii arkhiv · doi:10.17116/terarkh20168854-12 · Cited by 17
Postimplantation syndrome in endovascular aortic aneurysm repair – a systematic review
Bradley, N., Roxburgh, C. S. D., Khan, F., & Guthrie, G. J. K. (2020) · VASA · doi:10.1024/0301-1526/a000913 · Cited by 17
Integrated analysis of mRNA and miRNA expression in response to interleukin-6 in hepatocytes
Lukowski, S. W., Fish, R. J., Martin-Levilain, J., Gonelle‐Gispert, C., Bühler, L. H., Maechler, P., Dermitzakis, E. T., & Neerman‐Arbez, M. (2015) · Genomics · doi:10.1016/j.ygeno.2015.05.001 · Cited by 17
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma
Elhusseini, Z. W., Khalenkow, D., Lan, A., van der Molen, T., Brightling, C. E., Papi, A. A., Rabe, K. F., Siddiqui, S., Singh, D., Kraft, M., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02617-w · Cited by 17
He, F., Teng, X., Gu, H., Liu, H., Zhou, Z., Zhao, Y., Hu, S., & Zheng, Z. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045623 · Cited by 15
Cardiac Immunology: A New Era for Immune Cells in the Heart.
Koc, A., & Cagavi, E. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2020_576 · Cited by 15
Zegeye, M. M., Andersson, J. S. O., Wennberg, P., Repsilber, D., Sirsjö, A., & Ljungberg, L. U. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315793 · Cited by 16
Cholesterol and inflammation: The lesser the better in atherothrombosis
Rocha, V. Z., & Santos, R. D. (2018) · European Journal of Preventive Cardiology · doi:10.1177/2047487318772936 · Cited by 15
Thomas, M. R., James, S. K., Becker, R. C., Himmelmänn, A., Katus, H. A., Cannon, C. P., Steg, P. G., Siegbahn, A., Lakic, T. G., Storey, R. F., et al. (2019) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872619878075 · Cited by 16
Cardiovascular risk in psoriatic arthritis: How can we manage it?
Atzeni, F., Rodríguez‐Carrio, J., Alciati, A., Tropea, A., & Marchesoni, A. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103889 · Cited by 15
Global research trends in atherosclerosis: A bibliometric and visualized study
Tian, W., Zhang, T., Wang, X., Zhang, J., Ju, J., & Xu, H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.956482 · Cited by 18
Mahmood, Z., Davidsson, A., Olsson, E., Leanderson, P., Lundberg, A. K., & Jonasson, L. (2020) · Scientific Reports · doi:10.1038/s41598-020-78286-2 · Cited by 16
Akinyelure, O. P., Colantonio, L. D., Chaudhary, N. S., Jaeger, B. C., Judd, S. E., Cushman, M., Zakai, N. A., Kabagambe, E. K., Howard, V. J., Safford, M. M., et al. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.07.001 · Cited by 15
Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.
Ogata, A., Morita, T., Yoshida, Y., & Tanaka, T. (2015) · Therapeutic delivery · doi:10.4155/tde.14.118 · Cited by 14
Therapeutic Manipulation of Ageing: Repurposing Old Dogs and Discovering New Tricks
Mallikarjun, V., & Swift, J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.020 · Cited by 14
Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants
Lesmana, M. H. S., Le, N. Q. K., Chiu, W., Chung, K., Wang, C., Irham, L. M., & Chung, M. (2022) · Biomedicines · doi:10.3390/biomedicines10081947 · Cited by 15
Sartini, C., Whincup, P. H., Wannamethee, S. G., Jefferis, B. J. M. H., LENNON, L. T., Lowe, G. D. O., Welsh, P. I., Sattar, N. A., & Morris, R. W. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018264 · Cited by 14
Sherman, B. T., Hu, X., Singh, K., Haine, L., Rupert, A. W., Neaton, J. D., Lundgren, J. D., Imamichi, T., Chang, W., & Lane, H. C. (2020) · AIDS · doi:10.1097/qad.0000000000002738 · Cited by 15
Role of circulating molecules in age-related cardiovascular and metabolic disorders
Hsiao, Y., Shimizu, I., Yoshida, Y., & Minamino, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-021-00187-2 · Cited by 16
Anti-inflammatory strategies for atherosclerotic artery disease
Agnello, F. G., & Capodanno, D. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2036717 · Cited by 14
Thromboinflammation and Vascular Dysfunction
Karbach, S. H., Lagrange, J., & Wenzel, P. (2018) · Hämostaseologie · doi:10.1055/s-0038-1676130 · Cited by 14
Pretenders and Contenders: Inflammation, C‐Reactive Protein, and Interleukin‐6
Daniels, L. B. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007490 · Cited by 13
Bădilă, E., Japie, C., Vrabie, A.-M., Bădilă, A. E., & Georgescu, A. (2023) · Biomolecules · doi:10.3390/biom13020321 · Cited by 13
Genetic Risk Factors and Mendelian Randomization in Cardiovascular Disease
Swerdlow, D. I., Hingorani, A. D., & Humphries, S. E. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0584-x · Cited by 14
Karu, I., Starkopf, J., Zilmer, K., & Zilmer, M. (2013) · BioMed Research International · doi:10.1155/2013/985404 · Cited by 13
Zhu, T., Han, Q., Zhang, X., & Hou, Q. (2021) · PubMed Central · Cited by 13
Bradley, N., Roxburgh, C. S. D., McMillan, D. C., & Guthrie, G. J. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-20490-3 · Cited by 13
Lin, J., Wang, Y., Wang, Y., & Pan, Y. (2020) · Neurological Research · doi:10.1080/01616412.2019.1710404 · Cited by 13
Metadata
- Authors
- ‡
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- ‡
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 379
- Issue
- 9822
- Pages
- 1205-1213
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC3316940
- OpenAlex
- W2139957955
- Cited by
- 823
- References
- 47
- Citations by year
- 2026: 48 · 2025: 46 · 2024: 63 · 2023: 46 · 2022: 50 · 2021: 69 · 2020: 73 · 2019: 57 · 2018: 61 · 2017: 60 · 2016: 58 · 2015: 48 · 2014: 72 · 2013: 48 · 2012: 23
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Leicester Research Archive (University of Leicester) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- British Heart Foundation (RG/08/014)
- Bupa Foundation
- Medical Research Council
- NIHR Cambridge Biomedical Research Centre
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- IL-6 receptor, coronary artery disease, rs2228145, genetic association, inflammation, C-reactive protein, fibrinogen, interleukin-6, chronic inflammation, cardiovascular risk factors, monocytes, gene expression
- MeSH terms
- Coronary Disease, Gene Frequency, Humans, Risk Factors, Genetic Variation, Signal Transduction, Causality, Inflammation Mediators, Receptors, Interleukin-6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
